相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
Huimin Sun et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)
Circulating follicular helper T cells and subsets are associated with immune response to hepatitis B vaccination
Mingjuan Yin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
EMT, cancer stem cells and autophagy; The three main axes of metastasis
Ghader Babaei et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
Junlong Zhao et al.
MOLECULAR CANCER (2021)
Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
Anindita Bhattacharya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
PCSK9 and cancer: Rethinking the link
Khadijeh Mahboobnia et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Influence of cholesterol on cancer progression and therapy
Shyamananda Singh Mayengbam et al.
TRANSLATIONAL ONCOLOGY (2021)
The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
Nabil G. Seidah
JOURNAL OF LIPID RESEARCH (2021)
Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in ApcMin/+ mice
Kai Yang et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Michelangelo Certo et al.
NATURE REVIEWS IMMUNOLOGY (2021)
PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1
Zufeng Ding et al.
CARDIOVASCULAR RESEARCH (2020)
Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
Samir Devalaraja et al.
CELL (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Yuqiong Xia et al.
ADVANCED MATERIALS (2020)
Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor
Khaldoun S. Abdelwahed et al.
PHARMACOLOGICAL RESEARCH (2020)
Cholesterol metabolism in drug-resistant cancer (Review)
Aiwen Yan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Colorectal Cancer Immunotherapy: Options and Strategies
Nor Adzimah Johdi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9
Klaus-Dieter Schlueter et al.
FRONTIERS IN PHYSIOLOGY (2020)
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Xinjian Liu et al.
NATURE (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Justin C. Penticuff et al.
NATURE REVIEWS UROLOGY (2019)
GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition
Zhou Yang et al.
CANCER BIOLOGY & THERAPY (2019)
The relation between PI3K/AKT signalling pathway and cancer
Saeed Noorolyai et al.
GENE (2019)
PCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi-Borojeni et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer
Sorbarikor Piawah et al.
CANCER (2019)
Metabolic regulation of gene expression by histone lactylation
Di Zhang et al.
NATURE (2019)
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
Amir Abbas Momtazi-Borojeni et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis
Pingting Zhou et al.
CLINICA CHIMICA ACTA (2018)
O-GlcNAcylation in oral squamous cell carcinoma
Tassaporn Kongkaew et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner
M. Barbosa de Souza Rizzo et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Oxysterols selectively promote short-term apoptosis in tumor cell lines
Debora Levy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Membrane cholesterol access into a G-protein-coupled receptor
Ramon Guixa-Gonzalez et al.
NATURE COMMUNICATIONS (2017)
Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation
Caihua Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice
Claudia Lanterna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Cellular Cholesterol Directly Activates Smoothened in Hedgehog Signaling
Pengxiang Huang et al.
CELL (2016)
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
Hanxiao Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
Ciaran O'Reilly et al.
MEDICINAL RESEARCH REVIEWS (2016)
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
Rainer Schulz et al.
BASIC RESEARCH IN CARDIOLOGY (2015)
Targeting lactate metabolism for cancer therapeutics
Joanne R. Doherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
Kavitha Yaddanapudi et al.
JOURNAL OF IMMUNOLOGY (2013)
Phase 3 data for PCSK9 inhibitor wows
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
Control of the immune system by oxysterols and cancer development
Catia Traversari et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Epithelial-mesenchymal transitions: insights from development
Jormay Lim et al.
DEVELOPMENT (2012)
Proprotein Convertase Subtilisin/Kexin Type 9 Deficiency Reduces Melanoma Metastasis in Liver
Xiaowei Sun et al.
NEOPLASIA (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Lipogenesis Pathway as a Cancer Target
Hanley N. Abramson
JOURNAL OF MEDICINAL CHEMISTRY (2011)
PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities
Majambu Mbikay et al.
FEBS LETTERS (2010)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Affects Gene Expression Pathways Beyond Cholesterol Metabolism in Liver Cells
Hong Lan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9
Trine Ranheim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)